The effect of anxiolytic drug afobazole on the quality of life of patients with anxiety disorders

Abstract

The results of the quality of life (QoL) changes study during fabomotizole treatment in patients with anxiety disorders are presented. The QoL indexes measured with WHOQOL-BREF questionnaire in patients with anxiety disorders are significantly decreased compared to healthy persons. Fabomotizole treatment is associated with both positive changes in QoL and anxiety symptoms reduction. Given the need to treat anxiety disorders in outpatient settings and importance to maintain patient’s optimal social performance and QoL it is reasonable to use fabomotizole as the first line treatment.

Keywords

• тревожные расстройства
• качество жизни
• анксиолитическое средство
• афобазол
• клинико-фармакологическое исследование
• anxiety disorders
• quality of life
• anxiolytic
• fabomotizole
• clinical and pharmacological research